Editor-in-Chief
Ulka Vaishampayan, MD, Department of Oncology, Wayne State University, Detroit, United States
Scientific Advisory Board
Alexander O Vortmeyer, MD, PhD, IU Health Pathology Laboratory, 350 West 11th Street, Room 4034, Indianapolis, IN, United States
Glenda C Gobe, MSc, PhD, Centre for Kidney Disease Research, Translational Research Institute, School of Medicine, University of Queensland, Australia
Hemamali Samaratunga MBBS, LRCP MRCS, FRCPA, Aquesta Pathology, Toowong, Queensland, Australia
Keng Lim Ng, MBBS, MS, FRCS, PhD, Department of Urology, Princess Alexandra Hospital, Queensland, Australia
Rachel Giles, PhD, Dept. Nephrology and Hypertension, University Medical Center Utrecht, Utrecht, Netherlands
Tahseen Al-Saleem, MD, Fox Chase Cancer Center, USA, United States
W. Marston Linehan, MD, Urologic Oncology Branch, National Cancer Institute, MD, United States
Editorial Board Members
Yoshihide Ogawa, MD, PhD, Department of Urology, Towa Hospital, Japan, Japan
Benjamin L Maughan, MD, Pharm D, Genitourinary Medical Oncology, Division of Oncology, University of Utah, United States
Ulka Vaishampayan, MD, Department of Oncology, Wayne State University, Detroit, United States
Haifeng Yang, PhD, Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University Philadelphia, United States
Tien Hsu, PhD., Graduate Institute of Systems Biology and Bioinformatics, National Central University, Chungli,, Taiwan, Province of China
Ayyappan K Rajasekaran, PhD, Therapy Architects, LLC, Wilmington, DE, United States
Azad Hassan Abdul Razak, MBBS, FRCS, Department of Surgery, Faculty of Medicine, University of Malaya, Malaysia
Brunolf Walther Lagerveld, MD, PhD, Department of Urology, Onze Lieve Vrouwe Gasthuis (OLVG), Amsterdam, Netherlands
Camillo Porta, MD., Oncologia Medica, Fondazione I.R.C.C.S. Policlinico San Matteo, Pavia, Italy
Charles L Cowey, MD, Baylor Sammons Cancer Center, US Oncology Research, TX, United States
Daniel C Cho, MD, NYU Cancer Institute, New York, NY, United States
David A Vesey, PhD, The University of Queensland, Australia
Eric Jonasch, M.D., The University of Texas MD Anderson Cancer Center, Houston, TX, United States
Fumitaka Koga, MD,PhD, Department of Urology, Tokyo Metropolitan Cancer and Infectious Diseases Center, Japan
Guofei Zhou, PhD, Department of Pediatrics, University of Illinois at Chicago, IL, United States
Hiroshi Kanno, Department of Neurosurgery, International University of Health and Welfare, Japan
James Hsieh, M.D., Ph.D., Human Oncology & Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, NY, United States
Jasneet Singh Bhullar MD, MS, Department of Surgery, University of Minnesota, Minneapolis - St.Paul. MN, United States
Keng Lim Ng, MBBS, MS, FRCS, PhD, Department of Urology, Princess Alexandra Hospital, Queensland, Australia
Ramaprasad Srinivasan, MD, PhD, National Cancer Institute, NIH, United States
Roberto Pili, M.D., Robert Wallace Miller Professor of Oncology Director, Genitourinary Oncology Professor of Medicine, Urology, Pharmacology and Toxicology, Indiana University, School of Medicine – Simon Cancer Center, Indianapolis, IN 46202, United States
Samy L Habib, MS, PhD, The University of Texas Health Science Center at San Antonio, Department of Cellular and Structural Biology, San Antonio, TX, United States